The Global relapsed or refractory diffuse large B-cell lymphoma market is estimated to be valued at US$ 1777.75 Bn in 2024 and is expected to exhibit a CAGR of 16% over the forecast period 2024 To 2031. https://www.newswirestats.com/relapsed-or-refractory-diffuse-large-b-cell-lymphoma-market-size-and-trends-analysis/